UK markets closed

Chiasma, Inc. (CHMA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.8650-0.0550 (-1.88%)
As of 11:30AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close2.9200
Open2.9500
Bid2.8600 x 1400
Ask2.8700 x 1400
Day's range2.8300 - 2.9500
52-week range2.7700 - 7.7500
Volume302,388
Avg. volume1,739,313
Market cap165.722M
Beta (5Y monthly)1.38
PE ratio (TTM)N/A
EPS (TTM)-1.4320
Earnings date05 May 2021 - 10 May 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est13.60
  • Chiasma (NASDAQ:CHMA) Shareholders Have Enjoyed An Impressive 117% Share Price Gain
    Simply Wall St.

    Chiasma (NASDAQ:CHMA) Shareholders Have Enjoyed An Impressive 117% Share Price Gain

    Chiasma, Inc. ( NASDAQ:CHMA ) shareholders might be concerned after seeing the share price drop 27% in the last...

  • Chiasma (CHMA) Q4 2020 Earnings Call Transcript
    Motley Fool

    Chiasma (CHMA) Q4 2020 Earnings Call Transcript

    Except as required by law, Chiasma disclaims any obligation to update information contained in these forward-looking statements, whether as a result of new information, future events or otherwise. Joining the call today is Raj Kannan, chief executive officer; Anand Varadan, executive vice president and chief commercial officer; Bill Ludlam, senior vice president of Clinical Development and Medical Affairs; and John Doyle, senior vice president and chief financial officer.

  • Chiasma (CHMA) Reports Q4 Loss, Lags Revenue Estimates
    Zacks

    Chiasma (CHMA) Reports Q4 Loss, Lags Revenue Estimates

    Chiasma (CHMA) delivered earnings and revenue surprises of 8.57% and -17.75%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?